Picture of Bausch + Lomb logo

BLCO Bausch + Lomb Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Bausch + Lomb, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSARSARS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line303-1719315-248
Depreciation
Deferred Taxes
Non-Cash Items1065912160146
Unusual Items
Other Non-Cash Items
Changes in Working Capital-40-5928-19-287
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities799522873345-17
Capital Expenditures-180-253-193-175-181
Purchase of Fixed Assets
Other Investing Cash Flow Items-6-3-21-40-1,928
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-186-256-214-215-2,109
Financing Cash Flow Items-606-232-712-2,346-37
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-606-232-712812,078
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash446-61203-46